Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 112.946M	--
--	2024/Q4	-- / 98.260M	--
Nov 4, 2024	2024/Q3	83.879M / 81.705M	--
Aug 6, 2024	2024/Q2	73.466M / 65.893M	--
May 1, 2024	2024/Q1	63.474M / 54.608M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 112.946M--

--2024/Q4-- / 98.260M--

Nov 4, 20242024/Q383.879M / 81.705M--

Aug 6, 20242024/Q273.466M / 65.893M--

May 1, 20242024/Q163.474M / 54.608M--

Unlock Free Earnings Estimates

Open Account

TG Therapeutics Earnings Reports

TG Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 16:38 ET

TG Therapeutics | 8-K: ® TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI (ublituximab-xiiy) Full Year Revenue Guidance

Nov 4 07:24 ET

TG Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 9 16:12 ET

TG Therapeutics | 10-K/A: Annual report (Amendment)

Aug 9 16:03 ET

Trending US Stocks